ORGO FY 2022 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$355M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$451M-3.5% YoY

Gross Profit

$346M76.7% margin

Operating Income

$22M4.9% margin

Net Income

$16M3.4% margin

EPS (Diluted)

$0.12

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

-$9M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$449M

Total Liabilities

$184M

Stockholders' Equity

$266M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$451M	$467M	-3.5%
Gross Profit	$346M	$353M	-2.1%
Operating Income	$22M	$72M	-69.1%
Net Income	$16M	$94M	-83.5%